Boditech Med Inc. (KOSDAQ:206640)
South Korea · Delayed Price · Currency is KRW 12,650
-270 (-2.09%)
At close: Feb 6, 2026
Boditech Med Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 27,226 | 27,260 | 25,947 | 24,152 | 44,367 | 45,489 |
Depreciation & Amortization | 9,670 | 8,442 | 8,232 | 7,473 | 6,041 | 5,389 |
Loss (Gain) From Sale of Assets | 494.37 | 48.52 | -317.25 | -43.62 | 86.54 | -0.11 |
Asset Writedown & Restructuring Costs | -30.5 | - | - | 35.86 | 79.44 | 2,327 |
Loss (Gain) From Sale of Investments | -389.32 | -563.78 | -415.34 | -59.87 | 63.47 | -491.77 |
Loss (Gain) on Equity Investments | -2,015 | 497.31 | 113.95 | 390.07 | 407.01 | 309.4 |
Stock-Based Compensation | -36.05 | -66.32 | 221.53 | 110.36 | 56.51 | 10.55 |
Provision & Write-off of Bad Debts | -1,087 | 472.51 | 2,587 | 638.81 | 4,689 | 488.23 |
Other Operating Activities | -3,699 | -2,862 | 4,161 | -4,804 | -660.03 | 15,592 |
Change in Accounts Receivable | -2,044 | -3,070 | -10,487 | 2,184 | 4,914 | -22,116 |
Change in Inventory | -7,160 | -7,879 | -2,001 | -896.01 | -9,330 | -9,986 |
Change in Accounts Payable | -298.68 | 865.45 | 6,027 | -5,446 | 843.28 | 4,051 |
Change in Other Net Operating Assets | 131.96 | 1,733 | 231.81 | -664.24 | -1,629 | 3,579 |
Operating Cash Flow | 20,763 | 24,879 | 34,300 | 23,068 | 49,927 | 44,643 |
Operating Cash Flow Growth | -24.50% | -27.47% | 48.69% | -53.80% | 11.84% | 158.92% |
Capital Expenditures | -32,319 | -11,427 | -4,605 | -15,260 | -18,230 | -4,078 |
Sale of Property, Plant & Equipment | 446.9 | 1,433 | 174.6 | 312.74 | 182.5 | 282.44 |
Divestitures | - | - | 181.79 | - | 248.48 | - |
Sale (Purchase) of Intangibles | -1,300 | -1,041 | -1,025 | -1,595 | -181.71 | -213.32 |
Investment in Securities | -8,001 | -890.91 | -10,944 | -7,592 | 2,220 | -36,138 |
Other Investing Activities | -213.62 | -51.96 | 95.61 | -320.35 | 157.44 | 200.25 |
Investing Cash Flow | -41,387 | -11,978 | -16,122 | -24,454 | -15,603 | -39,946 |
Long-Term Debt Issued | - | 16,302 | 15,872 | 4,884 | 800 | 8,500 |
Long-Term Debt Repaid | - | -18,009 | -14,739 | -3,698 | -7,033 | -12,945 |
Net Debt Issued (Repaid) | 10,190 | -1,706 | 1,133 | 1,186 | -6,233 | -4,445 |
Issuance of Common Stock | 12.3 | 135.3 | 12.3 | 141.8 | 24.68 | 1,502 |
Repurchase of Common Stock | -7,941 | -2,964 | - | -7,219 | -8,750 | - |
Dividends Paid | -3,267 | -4,395 | -3,295 | -4,270 | -4,609 | -1,148 |
Other Financing Activities | 1,994 | 954.36 | 212.23 | -0 | -369.26 | -22 |
Financing Cash Flow | 987.67 | -7,976 | -1,938 | -10,162 | -19,937 | -4,114 |
Foreign Exchange Rate Adjustments | 636.55 | 525.64 | -7.28 | -1,008 | 383.97 | -357.79 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | -19,000 | 5,450 | 16,232 | -12,555 | 14,772 | 224.98 |
Free Cash Flow | -11,556 | 13,452 | 29,695 | 7,808 | 31,697 | 40,565 |
Free Cash Flow Growth | - | -54.70% | 280.32% | -75.37% | -21.86% | 223.62% |
Free Cash Flow Margin | -7.61% | 9.74% | 22.12% | 6.61% | 20.10% | 28.14% |
Free Cash Flow Per Share | -530.91 | 613.11 | 1351.72 | 349.13 | 1383.14 | 1761.80 |
Cash Interest Paid | 333.37 | 340.04 | 336.82 | 64.63 | 158.79 | 247.89 |
Cash Income Tax Paid | 6,073 | 6,190 | 2,672 | 8,036 | 11,879 | 2,137 |
Levered Free Cash Flow | -17,987 | 583.72 | 23,582 | -530.46 | 17,557 | 31,052 |
Unlevered Free Cash Flow | -17,778 | 804.03 | 23,801 | -403.01 | 17,680 | 31,344 |
Change in Working Capital | -9,371 | -8,350 | -6,229 | -4,823 | -5,202 | -24,472 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.